Semaglutide Linked to 15% Lower Fracture Risk: Bone Health Benefits for Type 2 Diabetes Patients
New research from ENDO 2026 reveals semaglutide reduces bone fracture risk by 15% in type 2 diabetes patients while delivering superior weight loss results.